Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Arbyn

Showing results (71-80 of 308) with videos related to

Pageof 31
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 22, 2024
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)Mario Poljak, Anja Oštrbenk Valenčak, Kate Cuschieri, et al.
Cancer Medicine|June 3, 2024
Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from ChinaChangchang Dun, Meiwen Yuan, Xuelian Zhao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 12, 2022
Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention CommitteeNadja Taumberger, Elmar A Joura, Marc Arbyn, et al.
Vaccine|December 17, 2013
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central AsiaFreddie Bray, Joannie Lortet-Tieulent, Ariana Znaor, et al.
The Lancet. Oncology|September 29, 2022
HPV mRNA testing in cervical cancer screening - Authors' replyMarc Arbyn, Karen Canfell, Mario Poljak, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 14, 2014
Early effects of human papillomavirus vaccination in BelgiumMireille Merckx, Davy Vanden Broeck, Ina Benoy, et al.
Vaccine|December 4, 2012
Nucleic acid tests for the detection of alpha human papillomavirusesMario Poljak, Jack Cuzick, Boštjan J Kocjan, et al.
Virology Journal|October 31, 2018
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screeningAjmal Akbari, Davy Vanden Broeck, Ina Benoy, et al.
Gynecologic Oncology|November 7, 2006
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studiesGeorge Koliopoulos, Marc Arbyn, Pierre Martin-Hirsch, et al.
BMJ (Clinical Research Ed.)|August 5, 2003
European Commission's proposal for a council recommendation on cancer screeningMarc Arbyn, Herman Van Oyen, Elsebeth Lynge, et al.
Pageof 31

Showing results (71-80 of 308) with videos related to

Sort By:
Pageof 31
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 22, 2024
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)Mario Poljak, Anja Oštrbenk Valenčak, Kate Cuschieri, et al.
Cancer Medicine|June 3, 2024
Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from ChinaChangchang Dun, Meiwen Yuan, Xuelian Zhao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 12, 2022
Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention CommitteeNadja Taumberger, Elmar A Joura, Marc Arbyn, et al.
Vaccine|December 17, 2013
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central AsiaFreddie Bray, Joannie Lortet-Tieulent, Ariana Znaor, et al.
The Lancet. Oncology|September 29, 2022
HPV mRNA testing in cervical cancer screening - Authors' replyMarc Arbyn, Karen Canfell, Mario Poljak, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 14, 2014
Early effects of human papillomavirus vaccination in BelgiumMireille Merckx, Davy Vanden Broeck, Ina Benoy, et al.
Vaccine|December 4, 2012
Nucleic acid tests for the detection of alpha human papillomavirusesMario Poljak, Jack Cuzick, Boštjan J Kocjan, et al.
Virology Journal|October 31, 2018
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screeningAjmal Akbari, Davy Vanden Broeck, Ina Benoy, et al.
Gynecologic Oncology|November 7, 2006
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studiesGeorge Koliopoulos, Marc Arbyn, Pierre Martin-Hirsch, et al.
BMJ (Clinical Research Ed.)|August 5, 2003
European Commission's proposal for a council recommendation on cancer screeningMarc Arbyn, Herman Van Oyen, Elsebeth Lynge, et al.
Pageof 31